Pennsylvania 340B health centers and hospitals are alarmed about a Dec. 22 state human services department notice to providers that 340B covered entities’ contract pharmacies “must dispense non-340B-purchased drugs to [Medicaid] beneficiaries in the [fee for service] and managed care
…
Avita, a leading provider of 340B contract pharmacy and third-party administration services geared toward HIV and LGBTQ+ communities, has acquired Q Care Plus, a business that helps patients access HIV pre-exposure prophylaxis (PrEP) medication by telehealth.
PMQ Investors LLC, Avita’s
…
Q: Where did you grow up?
I grew up in Boksburg, a small town outside of Johannesburg, South Africa.
Q: Where did you go to college/graduate school?
I
…
U.S. Rep. Matt Rosendale (R-Mont.) has introduced legislation reportedly the same as he filed during the last session of Congress to impose conditions on hospital participation in the 340B program. More bills dealing with 340B are likely.
…
U.S. Rep. Cathy McMorris Rodgers (R-Wash.) announced Tuesday that she was named chair of the House Energy & Commerce Committee. She in turn announced yesterday that the House Republican Steering Committee recommended nine new members to serve on the panel.
…
SPONSORED CONTENT
We are pleased to again bring you Visante’s Top 10 issues in pharmacy for 2023. For 2022, our Top 10 items (Pharmacy Org Structure, 340B Program, Vertical Integration & Marketplace Restrictions, Drug Prices & Supply Chain, Infusion Services, Drug Shortages, Pandemic, Economy, Election, Social Justice)
…
The American Hospital Association purchased a large ad in The Wall Street Journal print edition Tuesday touting the 340B program’s benefits and saying, “It is in the best interest of all to keep the 340B program strong.”
The quarter-page
…
An Ohio-based health system that was the focus of a New York Times investigation of alleged 340B program misuse opened a long-delayed medical office building this week near the Richmond, Va., hospital featured in the exposé.
Bon Secours Health System
…
The U.S. Centers for Medicare & Medicaid Services will publish the first 10 Medicare Part D drugs selected for the new Medicare Drug Price Negotiation Program by Sept. 1, CMS announced yesterday.
The negotiated maximum fair prices for these drugs
…
A federal district judge in Washington, D.C., this morning ruled that Medicare Part B underpayments to hospitals for 340B drugs from 2018 to 2022 were unlawful. But in a disappointment for the hospital groups that sued, the judge declined to
…*Sign up for news summaries and alerts from 340B Report
